Assessment and Impact of Cognitive Impairment in Multiple Sclerosis : an Overview

Loading...
Thumbnail Image
Date
2019
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Cognitive impairment affects 40-60% of patients with multiple sclerosis. It may be present early in the course of the disease and has an impact on a patient's employability, social interactions, and quality of life. In the last three decades, an increasing interest in diagnosis and management of cognitive impairment has arisen. Neuropsychological assessment and neuroimaging studies focusing on cognitive impairment are now being incorporated as primary outcomes in clinical trials. However, there are still key uncertainties concerning the underlying mechanisms of damage, neural basis, sensitivity and validity of neuropsychological tests, and efficacy of pharmacological and non-pharmacological interventions. The present article aimed to present an overview of the assessment, neural correlates, and impact of cognitive impairment in multiple sclerosis.
Description
Keywords
Multiple sclerosis, Demyelinating diseases, Cognitive impairment, Cognitive dysfunction
Citation